ETHYL 2-(4-CHLORO-2-NITROPHENYL)ACETATE, 95.0%, 1g

4-(4-bromobenzoyl)-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

Syringe filters Minisart® NY Non-sterile, 0,2 µm, 25 mm, 500 Piece(s)

4,4,4-Trifluoro-1-(1-methyl-1H-pyrazol-4-yl)-butane-1,3-dione, 500mg

(R)-2-Cbz-Amino-butane-1,4-diol, 95.0%, 1g

1-BENZYL-4-HYDRAZINOPIPERIDINE, 95.0%, 250mg

3-(Fluorosulfonyl)-5-((trimethylsilyl)ethynyl)benzoic acid, 98%, 25mg

4-(4-Biphenylyl)-2-(3-pyridyl)thiazole, 250mg

(S)-Oxetan-2-ylmethanamine hydrochloride, 98%, 5g

(1-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroquinolin-6-yl)boronic acid, 95.0%, 1g

3-(3-Methylbenzoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-amine, 97%, 100mg

GNF-5, 95%, 100mg

2,6-Dichlorophenolindophenol sodium salt, AR, ACS, 1 g, glass packaging